Добавил:
Sekretar
kiopkiopkiop18@yandex.ru
t.me/Prokururor I Вовсе не секретарь, но почту проверяю
Опубликованный материал нарушает ваши авторские права? Сообщите нам.
Вуз:
Предмет:
Файл:Ординатура / Хирургия / Библиотека им академика М.И. Перельмана / Книга_1250_Библиотеки_им_академика_М_И_Перельмана.pdf
X
- •Foreword
- •Preface
- •Contents
- •Contributors
- •General
- •1 Redefining the Mesentery as an Organ
- •Definition of the Mesentery
- •Historic Development of the Understanding of the Mesentery
- •Conclusion
- •Suggested Reading
- •2 Embryology of the Mesentery
- •Introduction
- •Embryological Development of the Mesentery and Related Organs
- •The Ventral and Dorsal Mesentery
- •Development of the Upper Region of Mesentery and Associated Organs
- •Development of the Lower Region of Mesentery and Associated Organs
- •Development of the Peritoneum and Peritoneal Cavity
- •Migration Across the Mesentery
- •Regenerative Capacity of the Mesentery and Bioengineering of Abdominal Digestive Organs
- •The Science of the Mesentery
- •Suggested Reading
- •3 General Anatomy of the Mesentery
- •Introduction
- •The Mesentery
- •The Dorsal Mesogatsrium and Mesoduodenum
- •The Greater Omentum
- •The Lower Region of Mesentery
- •Small Bowel Mesentery and Right Mesocolon
- •Mesocolon Distal to Transverse Mesocolon
- •Mesosigmoid and Mesorectum
- •Mechanisms of Attachment
- •Central Mechanisms of Attachment
- •Intermediate Mechanism of Attachment
- •The Peritoneal Reflection
- •Abdominal Digestive System Surgery
- •Suggested Reading
- •Anatomy and Physiology
- •4 Vascular Anatomy of the Mesentery
- •Introduction
- •Suggested Reading
- •5 Introduction to the Physiology of the Mesentery
- •Anatomy
- •Vascular Physiology
- •Immunologic Physiology
- •Neuronal Physiology
- •Role of Mesenteric Adipose
- •Suggested Reading
- •6 Emergence of the Human Gut Microbiota as an Influencer in Health and Disease
- •The Gut Microbiome
- •Bacterial Translocation to Blood and the Mesentery
- •The Microbiome of Mesenteric Fat
- •The Microbiome of Mesenteric Lymph Nodes
- •The Mesentery—A Reservoir for Pathogenic Bacteria?
- •Mesenteric Abscess—A Special Microenvironment for Pathogenic Bacteria in Inflammatory Bowel Disease?
- •Conclusion
- •Suggested Reading
- •7 Cellular Anatomy of the Mesentery
- •Introduction
- •Mesenteric Histology
- •Gene Expression and Protein Synthesis in the Mesentery
- •Mesenteric Derived Mesothelial Cells
- •Connective Tissue Continuity
- •Mesenteric Adipocytes
- •Fibrocytes
- •The Peritoneal Reflection
- •Conventional Angiography
- •Description of Procedure
- •Indications
- •Complementary Procedures
- •Contraindications
- •Preparation of Patient
- •How the Procedure Is Performed
- •Complications
- •PET Scan
- •Description of Procedure
- •Indications
- •Complementary Procedures
- •Relative Contraindications
- •Histology of Toldt’s Fascia
- •The Mesentery in Disease States
- •Future Directions
- •Suggested Reading
- •Diagnostic Procedures
- •8 Radiography of the Mesentery
- •Plain Films of the Abdomen
- •Description of Procedure
- •Indications
- •Complementary Procedures
- •Contraindications
- •Preparation of Patient
- •How the Procedure Is Performed
- •Typical Abnormal Findings
- •Complications
- •Computed Tomography (CT)
- •Description of Procedure
- •Indications
- •Complementary Procedures
- •Contraindications
- •Relative Contraindications
- •Preparation of Patient
- •How the Procedure Is Performed
- •Typical Abnormal Findings
- •Complications
- •Additional Comments
- •Magnetic Resonance Imaging (MRI)
- •Description of Procedure
- •Contraindications
- •Relative Contraindications
- •Preparation of Patient
- •How the Procedure Is Performed
- •Typical Abnormal Findings
- •Complications
- •Preparation of Patient
- •How the Procedure Is Performed
- •Typical Abnormal Findings
- •Complications
- •Additional Comments
- •Ultrasound
- •Description of Procedure
- •Indications
- •Complementary Procedures
- •Contraindications
- •Relative Contraindications
- •Preparation of Patient
- •How the Procedure Is Performed
- •Typical Abnormal Findings
- •Complications
- •Additional Comments
- •Suggested Reading
- •9 Mesenteric Biopsy
- •Indications
- •Contraindications
- •Description of the Procedure
- •Preparation of Patient
- •Image-Guided Percutaneous Mesenteric Biopsy
- •Diagnostic Laparoscopic Mesenteric Biopsy
- •Complications
- •Suggested Reading
- •10 Diagnosing Mesenteric Diseases: Laparoscopy
- •Indications
- •Traumatic Injury
- •Inflammatory Bowel Disease
- •Neoplastic Disease
- •Pediatric Applications
- •Ischemia
- •Internal Hernia
- •Contraindications
- •Complementary Procedures
- •Intra-operative Perfusion Assessment with Fluorescence
- •Preparation of the Patient
- •Technical Details
- •Abdominal Entry
- •Exploration of the Peritoneal Cavity and Mesentery
- •Abdominal Closure
- •Suggested Reading
- •11 Immunologic Function of the Mesentery
- •Introduction
- •Innate and Adaptive Responses of the Immune System
- •Mesenteric-Specific Immune Cells
- •Mesenteric Immunity and Crohn’s Disease (Also See Chap. 15 Crohn’s Disease)
- •Summary
- •Suggested Reading
- •12 Neurophysiologic Function of the Mesentery
- •Anatomy
- •The Sympathetic Nervous System
- •The Parasympathetic Nervous System
- •Neurologic Regulation of Mesenteric Blood Flow
- •Arterial and Venous Innervation
- •Arterial and Venous Components of Blood Pressure Regulation
- •Neuronal Control of Mesenteric Arteries and Veins
- •Anatomic Organization of Sympathetic Innervation of the Large Intestine
- •Activation of Vascular Innervation by Peripheral Reflexes
- •Innervation of the Lymphatic Vessels
- •The Mesenteric Nervous System and Inflammation
- •Suggested Reading
- •13 Physiology of the Mesenteric Circulation
- •Introduction
- •Review of Mesenteric Microcirculation and Fluid Dynamics
- •Mesenteric Microcirculation
- •Fluid Dynamics
- •The Intrinsic System
- •Metabolic Pathway
- •Oxygen Demand and Supply
- •Metabolic Byproducts
- •Intraluminal Hyperosmolarity
- •Myogenic Pathway
- •Extrinsic System
- •Central Cardiovascular Control
- •Autonomic Neuro-Regulation
- •Sympathetic Nervous System (SNS) Stimulation
- •Parasympathetic Nervous System (PNS) Stimulation
- •Neurohumoral Control
- •Catecholamines
- •Angiotensin II
- •Vasopressin
- •Suggested Reading
- •14 The Role of the Mesentery in Metabolic Syndrome and Diabetes Mellitus
- •Introduction
- •Pathogenesis
- •Treatment
- •Suggested Reading
- •15 Crohn’s Disease and the Mesentery
- •Introduction
- •Mesenteric Immunity and Crohn’s Disease
- •Crohn’s Disease and Fat Wrapping
- •Imaging Studies of the Mesentery in Crohn’s Disease
- •Mesenteric Disorders that Are Associated with Crohn’s Disease
- •Inflammatory Disorders of the Mesentery and Inflammatory Bowel Disease
- •Suggested Reading
- •16 The Role of the Mesentery in Pancreatic Diseases
- •Embryology of the Pancreas and Pancreatic Mesentery
- •Pancreatic Diseases
- •Acute Pancreatitis
- •Mesenteric Panniculitis Involving the Pancreas and Pancreatic Panniculitis
- •Heterotopic Pancreas
- •Suggested Reading
- •Embryology
- •Pancreatitis and Other Diseases
- •Panniculitis
- •Heterotopic Pancreas
- •17 IgG4-Related Diseases and the Mesentery
- •Introduction
- •Pathogenesis
- •Clinical Manifestations
- •Type 1 Autoimmune Pancreatitis (AIP)
- •IgG4-Related Sclerosing Cholangitis (SC)
- •Retroperitoneal Fibrosis, Chronic Sclerosing Aortitis and Periaortitis
- •Diagnosis of IgG4-RD
- •Treatment
- •Suggested Reading
- •18 Role of the Mesentery in Systemic Inflammation Response Syndrome (SIRS) and Multiple Organ Dysfunction Syndrome (MODS)
- •Introduction
- •Pathophysiology
- •MODS Pathophysiology
- •Mesenteric Lymph, SIRS and MODS
- •Interventions Directed at Mesenteric Lymph
- •Mesenteric Duct Ligation and the Inflammatory Response
- •Vagal Nerve Stimulation (VNS)
- •Adipocytes, SIRS and MODS
- •Adiponectin, SIRS and MODS
- •Leptin, SIRS and MODS
- •CRP, Resistin and SIRS/MODS
- •Fibrocytes, SIRS and MODS
- •Summary
- •Suggested Reading
- •Medical Disorders of the Mesentery
- •19 Mesenteric Hemorrhage
- •Definition
- •Epidemiology and Risk Factors
- •Pathophysiology
- •Symptoms
- •Physical Findings
- •Imaging and Diagnosis
- •Management
- •Suggested Reading
- •20 Mesenteric Panniculitis
- •Definition and Nomenclature
- •Epidemiology
- •Patients at Risk
- •Pathophysiology
- •Symptoms and Signs
- •Diagnosis
- •Physical Findings
- •Laboratory Testing
- •Imaging
- •Biopsies and Histologic Findings
- •Treatments
- •Medical
- •Surgery
- •Sugggested Reading
- •21 PPP Syndrome: Pancreatitis, Panniculitis, Polyarthritis
- •Definition
- •Epidemiology
- •Patients at Risk
- •Pathophysiology
- •Signs and Symptoms
- •Diagnosis
- •Physical Findings
- •Laboratory Testing
- •Imaging
- •Histologic Findings
- •Treatments
- •Medical
- •Surgical
- •Additional Comments
- •Suggested Reading
- •22 Mesenteric Adenitis
- •Definition
- •Epidemiology
- •Patients At Risk
- •Pathophysiology
- •Symptoms
- •Physical Findings
- •Laboratory Testing
- •Imaging
- •Treatment
- •Medical
- •Surgical
- •Suggested Reading
- •23 Mesenteric Abscess
- •Definition
- •Pathophysiology
- •Epidemiology
- •Symptoms
- •Physical Findings
- •Laboratory Testing
- •Diagnosis and Imaging
- •Treatment
- •Suggested Reading
- •24 Mesenteric Venous Thrombosis
- •Introduction
- •Epidemiology
- •Anatomy
- •Pathophysiology
- •Patient At Risk for MVT
- •Clinical Presentation
- •Diagnosis
- •Imaging
- •Laboratory Findings
- •Treatment
- •Nonoperative Management
- •Interventional Radiology Procedures
- •Surgery
- •Prognosis
- •Suggested Reading
- •25 Mesenteric Arterial Occlusion
- •Definition and Description of the Disease
- •Epidemiology
- •Anatomy
- •Pathophysiology
- •Signs and Symptoms
- •Diagnosis
- •Physical Findings
- •Laboratory Findings
- •Imaging
- •Treatment
- •Overview
- •Surgical
- •Surgical Revascularization
- •Endovascular Procedures
- •Medical Therapy
- •Prognosis
- •Suggested Reading
- •26 Ischemic Enteropathy (Also Called Mesenteric Ischemia)
- •Definition and Description of the Disease
- •Classification and Terminology
- •Intestinal Vascular Anatomy
- •Epidemiology
- •Patients at Risk
- •Pathophysiology
- •Acute Mesenteric Ischemia of Arterial Origen
- •SMA Thrombosis (SMAT)
- •Nonocclusive Mesenteric Ischemia (NOMI)
- •Focal Segmental Ischemia (FSI)
- •Acute Mesenteric Ischemia of Venous Origen (MVT)
- •Signs and Symptoms of Ischemic Enteropathy
- •Diagnosis
- •Physical Findings
- •Laboratory Findings
- •Imaging
- •Histologic Findings
- •Treatments for Acute Mesenteric Ischemia
- •Medical
- •Surgical
- •Treatments for Chronic Mesenteric Ischemia
- •Medical
- •Surgical
- •Prognosis
- •Suggested Reading
- •27 Colonic Ischemia (Also Known as Ischemic Colitis)
- •Introduction
- •Epidemiology
- •Risk Factors
- •Pathophysiology
- •Clinical Presentations
- •Diagnosis
- •Laboratory Findings
- •Imaging
- •Colonoscopy
- •Histologic Findings
- •Treatments
- •Medical
- •Complications
- •Suggested Readings
- •28 Mesenteric Lymphangioma
- •Definition
- •Epidemiology
- •Patients at Risk
- •Pathophysiology
- •Clinical Presentation
- •Physical Findings
- •Laboratory
- •Histology
- •Imaging
- •Diagnosis
- •Treatment
- •Medical
- •Surgery
- •Suggested Reading
- •29 Radiation-Induced Mesenteric Injury
- •Pathophysiology of Radiation-Induced Tissue Injury
- •Radiation-Induced Intestinal Injury-Enteropathy and Colopathy
- •Medical Literature on Radiation and the Mesentery
- •Basic Research
- •Clinical Publications
- •Summary
- •Suggested Reading
- •30 Drug Induced Mesenteric and Retroperitoneal Diseases
- •Definition
- •Epidemiology
- •Patients at Risk
- •Pathophysiology
- •Diagnosis, Physical Findings and Laboratory Findings
- •Imaging
- •Treatment
- •Prognosis
- •Angiotensin Converting Enzyme (ACE)-Inhibitor Induced Visceral Edema
- •Definition
- •Epidemiology
- •Patients at Risk
- •Pathophysiology
- •Signs and Symptoms
- •Laboratory Findings
- •Imaging
- •Drug Induced Retroperitoneal Fibrosis
- •Definition, Description, and Epidemiology
- •Pathophysiology
- •Diagnosis, Physical Findings and Laboratory Findings
- •Imaging
- •Histologic Findings
- •Treatments
- •Surgical
- •Prognosis
- •Drug Induced Pancreatitis
- •Introduction
- •Suggested Reading
- •Neoplasms of the Mesentery
- •31 Primary Solid Neoplasms
- •Introduction
- •Desmoid Tumor of the Mesentery
- •Symptoms and Signs
- •Pathophysiology
- •Diagnosis
- •Treatment
- •Prognosis
- •Primary Leiomyosarcoma of the Mesentery
- •Symptoms and Signs
- •Pathophysiology
- •Diagnosis
- •Treatment
- •Prognosis
- •Primary Carcinoid Tumors of the Mesentery
- •Symptoms and Signs
- •Pathophysiology
- •Diagnosis
- •Treatment
- •Prognosis
- •Primary Liposarcoma of the Mesentery
- •Symptoms and Signs
- •Pathophysiology
- •Diagnosis
- •Treatment
- •Prognosis
- •Primary Stromal Tumor of the Mesentery
- •Symptoms and Signs
- •Pathophysiology
- •Diagnosis
- •Treatment
- •Prognosis
- •Summary
- •Suggested Reading
- •32 Metastatic Diseases of the Mesentery
- •Symptoms
- •Pathophysiology
- •Diagnosis
- •Treatment
- •Malignant Bowel Obstructions and Palliative Care
- •Conclusion
- •Suggested Reading
- •33 Mesenteric Lymphoma
- •Symptoms and Signs
- •Pathophysiology
- •Diagnosis
- •Treatment
- •Prognosis
- •Summary
- •Suggested Reading
- •34 Castleman Disease with Mesenteric Involvement
- •Definition and Description of the Disease
- •Epidemiology
- •Patients at Risk
- •Pathophysiology
- •Signs and Symptoms
- •Diagnosis
- •Physical Findings
- •Laboratory Findings
- •Imaging
- •Histologic Findings
- •Treatments
- •Prognosis
- •Suggested Reading
- •Surgical Diseases of the Mesentery
- •35 Mesenteric Resection in Upper Abdominal Surgery
- •Indications for Surgery
- •Contraindications
- •Description of Surgery
- •Small Bowel Resection with Adjacent Mesentery (Open Approach, Hand Sewn Anastomosis)
- •Complications
- •Summary
- •Suggested Reading
- •36 Mesenteric Considerations in Surgery of the Colon and Rectum
- •Introduction
- •Mesenteric Role in Diseases of the Colon and Rectum
- •Malignancy
- •Benign Disease
- •Colon Cancer Principles
- •Studies of Anatomy and Embryology
- •Surgical Principles
- •Preoperative Vascular Anatomical Considerations
- •Surgical Approach
- •Surgical Management of Colon Cancer
- •Cecal and Ascending Colon Carcinoma
- •Hepatic Flexure Carcinoma
- •Transverse Colon Carcinoma
- •Splenic Flexure Carcinoma
- •Descending Colon Carcinoma
- •Sigmoid Carcinoma
- •Total Mesorectal Excision Principles
- •Surgical Quality
- •Surgical Complications
- •Conclusion
- •Suggested Readings
- •37 Mesocolic Resection in Colon Cancer
- •Description of the Procedure
- •Indications
- •Contraindications
- •Preparation of the Patient
- •How the Procedure Is Performed
- •General Principles
- •Specific Considerations
- •Right Colon
- •Transverse Colon and Flexures
- •Left and Sigmoid Colon
- •Anatomical Variants and Typical Abnormal Findings
- •Complications
- •Outcomes
- •Conclusion
- •Suggested Reading
- •38 Mesenteric Resection in Rectal Cancer
- •Description of Rectal Cancer and the Mesorectum
- •Indications for Surgery of the Rectum and Mesorectum
- •Contraindications of Surgery of the Rectum and Mesorectum
- •Surgical Management: Technique
- •Surgical Complications
- •Early
- •Late
- •Summary
- •Suggested Readings
- •39 Mesenteric Resection in Crohn’s Disease
- •Introduction
- •Gross Features of the Bowel and Mesentery in Crohn’s Disease
- •Histopathologic Features of the Bowel and Mesentery in Crohn’s Disease
- •Mesenteric Adipose Tissue and Crohn’s Disease
- •Lymphatic System, Mesenteric Lymph Nodes Granulomas and Crohn’s Disease
- •Timing of Mesenteric Events in CD
- •Risk Factors for Recurrence and Extended Mesenteric Resection
- •Mesenteric Resection in Crohn’s Disease
- •Conclusion
- •Suggested Reading
- •40 Mesenteric Resection in Crohn’s Disease
- •Introduction
- •Inclusion of the Mesentery During Ileocolic Resection
- •Long-Term Outcomes
- •Short Term Outcomes
- •Indications for Inclusion of the Mesentery During Surgery for Crohn’s Disease
- •The Mesenteric Transition Zone
- •Advanced Mesenteric Disease Predicts Increased Surgical Recurrence
- •Discussion
- •Conclusion
- •Suggested Reading
- •Surgery for Individual Conditions
- •41 Surgical Management of Intestinal Volvulus
- •Definition and Clinical Features
- •Description of Surgery
- •Indications for Surgery
- •Contraindications
- •Preparation of Patient
- •How the Procedures Are Performed
- •Typical Abnormal Findings
- •Alternatives to Surgery
- •Outcomes
- •Complications
- •Summary
- •Suggested Reading
- •42 Embryologic Abnormalities of the Mesentery
- •Background
- •Malrotations and Indications for Surgery
- •Surgeries for Malrotations and Mesocolic Hernias
- •Complications
- •Summary
- •Suggested Reading
- •43 Mesenteric Hernia
- •Background
- •Clinical Presentation
- •Diagnosis
- •Management
- •Summary
- •Suggested Reading
- •44 Surgical Management of Bands and Adhesions
- •Definition and Clinical Features
- •Description of Procedures
- •Indications for Surgery
- •Contraindications
- •Preparation of the Patient
- •How the Procedure is Performed
- •Typical Abnormal Findings M
- •Outcomes and Complications
- •Summary
- •Suggested Reading
- •45 Mesenteric Trauma
- •Epidemiology
- •Pathophysiology
- •Diagnosis
- •Clinical Exam
- •Diagnostic Peritoneal Lavage (DPL) and Focused Assessment with Sonography in Trauma (FAST)
- •Operative Assessment
- •Grading
- •Predictive Variables
- •Management
- •Concern for Injury
- •High Suspicion for Injury
- •Intraoperative Finding
- •Proximal Mesenteric Injury
- •Future Directions
- •Suggested Reading
- •46 Mesenteric Cysts
- •Cystic Tumors of the Mesentery
- •Description of Condition
- •Mesenteric Lymphangioma
- •Simple Mesothelial Cysts
- •Multicystic Mesothelioma
- •Enteric Duplication Cysts
- •Urogenital Cysts of the Mesentery
- •Mature Cystic Teratoma
- •Mesenteric Pseudocyst
- •Presentation and Diagnosis
- •Diagnostic Studies in Uncomplicated Mesenteric Cysts
- •Physical Exam
- •Imaging
- •Lymphangioma
- •Mesothelial Cysts
- •Multicystic Mesothelioma
- •Enteric Duplication Cysts
- •Mature Cystic Teratoma
- •Mesenteric Pseudocyst
- •Endoscopy and Endoscopic Ultrasound
- •Acute Complications of Mesenteric Cysts
- •Obstruction, Volvulus and Intussusception
- •Ureteral Obstruction
- •Cyst Rupture
- •Cyst Hemorrhage
- •Infected Mesenteric Cyst
- •Peptic Ulceration
- •Management
- •Indications for Surgery
- •Contraindications to Surgery
- •Surgical Options
- •Summary
- •Suggested Reading
- •47 Mesenteric Abscess
- •Description of the Condition
- •Diagnosis of Mesenteric Abscess
- •Management of Mesenteric Abscess
- •Indications, Contraindications, and Challenges of Surgery for Mesenteric Abscess
- •Complications of Mesenteric Abscess
- •Outcome of Mesenteric Abscess
- •Summary
- •Colonic Abscess
- •Definition and Incidence
- •Causes
- •Diagnosis
- •Treatment
- •Conclusions
- •Suggested Reading
- •48 Mesenteric Neoplasms
- •Introduction
- •Description of Mesenteric Neoplasms
- •Lymphoma
- •Desmoid Tumors
- •Mesenteric Gastrointestinal Stromal Tumors
- •Mesenteric Carcinoid Tumors
- •Mesenteric Liposarcoma
- •Castleman’s Disease
- •Cystic Lesions
- •Conclusions
- •Suggested Reading
- •49 Mesenteric Artery Thrombosis and Embolism
- •Description of This Condition
- •Anatomy and Pathophysiology
- •Presentation
- •Laboratory Findings
- •Imaging Workup
- •Treatment
- •Outcomes
- •Suggested Readings
- •Future
- •50 Future Research on the Role of the Mesentery in Health and Disease
- •Introduction
- •Genetic Investigations and Mesenteric Disease
- •Clinical Pharmacology
- •Mesenteric Panniculitis
- •New and Future Developments in Mesenteric Surgery
- •Inflammatory Bowel Disease
- •Radiologic Advances
- •Mesenteric and Bowel Injuries
- •Fluorescence Lymphangiography
- •Use of Next Generation Technology to Advance Our Understanding of the Role of the Mesentery in Human Disease
- •Suggested Reading
- •Medical and Pharmacology
- •Surgery
- •Radiology
- •Next Generation Technology
- •Index

166 C. G. Pulido and E. D. Ehrenpreis
Fibrocytes contribution to the inflammatory process is facilitated by TNF-a and
IL-1b (as well as endotoxin in some infectious cases). They secrete a variety of
pro-inflammatory cytokines (including IL-6, IL-8, IL-10, and TNF-a). These are
involved in the induction of leukocyte entry, survival, and retention during inflammation
as well as the recruitment of other cells that promote the expansion of the inflammatory
reaction. IL-6 production is associated with the translocation of the NF-jB transcription
factor, that was previously described to be related to SIRS development. Fibrocytes also
secrete products such as Connective Tissue Growth Factor (CTGF) and Transforming
Growth Factor Beta 1 (TGF-b1). These promote tissue remodeling by stimulating
extracellular matrix assembly by local fibroblasts. Pilling et al. have postulated that the
positive feedback loop involving signals from fibroblasts back to fibrocytes may lead to
the persistence of inflammatory and a maladaptive repair process. This mechanism may
account for the supporting participation of fibrocytes in the development of SIRS and
perhaps with the progression of SIRS to MODS.
Summary
Although inflammation is an essential host response, the onset and progression of
infection, trauma, and ischemia can lead to both pro-inflammatory and
anti-inflammatory reactions. A subsequent chain of events can result in the establishment of SIRS and, in some cases, to MODS. Mesenteric components, including the
mesenteric lymph, adipocytes, fibrocytes and cytokines play a key role in regulating
pro-inflammatory and anti-inflammatory reactions that occur during the development of
SIRS and MODS. In the future, interventions directed at some of these mesenteric
components may represent therapeutic options for SIRS and MODS.
Suggested Reading
1. Rivera ED, Coffey JC, Walsh D, Ehrenpreis ED. The mesentery, systemic inflammation, and
Crohn’s Disease. Inflamm Bowel Dis. 2019;25(2):226–34.
2. Balk RA. Systemic inflammatory response syndrome (SIRS): Where did it come from and is it
still relevant today? Virulence. 2014;5(1):20–6.
3. Ward NS, Casserly B, Ayala A. The compensatory anti-inflammatory response syndrome
(CARS) in critically ill patients. Clin Chest Med. 2008; 29(4): 617–viii.
4. García de Alba C, Buendia-Roldán I, Becerril C, Ramírez R, González Y, Checa M,
Navarro C, Ruiz V, Pardo A, Selman M (Instituto Nacional de Enfermedades Respiratorias
Ismael Cosío Villegas, Mexico City, Mexico). Fibrocytes contribute to inflammation and
fibrosis in chronic hypersensitivity pneumonitis through paracrine effects. Am J Respir
Crit Care Med. 2015; 19(4):427–436. https://doi.org/10.1164/rccm.201407-1334OC.
5. Pilling D, Vakil V, Cox N, Gomer RH. TNF-a–stimulated fibroblasts secrete lumican to
promote fibrocyte differentiation. Proc Natl Acad Sci USA. 2015; 112(38): 11929–11934.
https://doi.org/10.1073/pnas.1507387112.
6. Galligan C, Fish E. The role of circulating fibrocytes in inflammation and autoimmunity.
J Leukoc Biol 2013; 93: 45–50. https://doi.org/10.1189/jlb.0712365.

18 Role of the Mesentery in Systemic Inflammation … 167
7. Balmelli C, Alves MP, Steiner E, Zingg D, Peduto N, Ruggli N, Gerber H, McCullough K,
Summerfield A (Institute of Virology and Immunoprophylaxis, Sensemattstrasse 293, CH-3147
Mittelhäusern, Switzerland). Responsiveness of fibrocytes to toll-like receptor danger signals.
Immunobiology. 2007; 212(9–10): 693-699. https://doi.org/10.1016/j.imbio.2007.09.009.
8. Du Clos TW (The VA Medical Center and the University of New Mexico School of
Medicine, Department of Medicine, Albuquerque, USA. tduclos@unm.edu). Function of
C-reactive protein. Ann Med. 2000; 32(4):274–278.
9. Bone RC (Medical College of Ohio, Toledo, USA). Toward a theory regarding the
pathogenesis of the systemic inflammatory response syndrome: what we do and do not know
about cytokine regulation. Crit Care Med. 1996; 24(1):163–72. https://insights.ovid.com/
pubmed?pmid=8565523.
10. Deshmane SL, Kremlev S, Amini S, Sawaya BE. Monocyte chemoattractant protein-1
(MCP-1): an overview. J Interferon Cytokine Res. 2009; 29(6): 313–326. https://doi.org/10.
1089/jir.2008.0027.
11. Livingston M. The pathophysiology of multiple organ dysfunction syndrome. https://doi.org/
10.13140/rg.2.2.19242.26569. Accessed 1 July 2019.
12. Bone RC. Immunologic dissonance: a continuing evolution in our understanding of the
systemic inflammatory response syndrome (SIRS) and the multiple organ dysfunction
syndrome (MODS). Ann Intern Med. 1996; 125(8):680–687. https://doi.org/10.7326/0003-
4819-125-8-199610150-00009.
13. Fanous MY, Phillips AJ, Windsor JA. Mesenteric lymph: the bridge to future management of
critical illness. JOP. 2007; 8(4):374–399. http://pancreas.imedpub.com/mesenteric-lymph-the-
bridge-to-future-management-of-critical-illness.pdf.
14. Tretjakovs P, Rautiainena L, Krievina G, Jurka A, Grope I, Gardovska D. Changes in serum
high-molecular-weight adiponectin levels in critically ill children with systemic inflammatory
response syndrome. Open Med J. 2016; 3:166–170. https://doi.org/10.2174/187422030
1603010166.
15. Grigoras I, Branisteanu DD, Ungureanu D, Rusu D, Ristescu I. Early dynamics of leptin
plasma level in surgical critically ill patients: a prospective comparative study. Chirurgia (Bucur). 2014; 109 (1):66–72. http://revistachirurgia.ro/pdfs/2014-1-66.pdf.
16. Zhang LM, Jiang LJ, Zhao ZG, Niu CY. Mesenteric lymph duct ligation after hemorrhagic
shock enhances the ATP level and ATPase activity in rat kidneys. Ren Fail. 2014; 36(4):593–
597. https://doi.org/10.3109/0886022x.2014.882183.
17. Kaplan LJ, Pinsky MR. Medscape. New York (NY): WebMD; 2018. https://emedicine.
medscape.com/article/168943-overview.
18. Ruan H, Dong LQ. Adiponectin signaling and function in insulin target tissues. J Mol Cell
Biol. 2016; 8(2):101–109. https://doi.org/10.1093/jmcb/mjw014.
19. Paz-Filho G, Mastronardi C, Bertoldi Franco C, Boyang Wang K,Wong ML,
Licinio J. Leptin: molecular mechanisms, systemic pro-inflammatory effects, and clinical
implications. Arq Bras Endocrinol Metabol. 2012; 56(9). http://dx.doi.org/10.1590/S0004-
27302012000900001.
20. Rudemiller NP, Crowley S. Interaction between the immune and renin angiotensin system in
hypertension. Hypertension. 2016;68(2):289–296.
116.06591.
21. Zabetian-Targhi F, Mahmoudi MJ, RezaeiN, Mahmoudi M. Retinol binding protein 4 in
relation to diet, inflammation, immunity, and Cardiovascular Diseases. Adv Nutr. 2015; 6
(6):748–762. https://doi.org/10.3945/an.115.008292.
22. Livingston M. The pathophysiology of multiple organ dysfunction syndrome [dissertation on
the Internet]. Leicester (England): The University of Birmingham; 2009; 88p. https://doi.org/
10.13140/rg.2.2.19242.26569.
https://doi.org/10.1161/hypertensionaha.

Part V
Medical Disorders of the Mesentery

Mesenteric Hemorrhage
Ryan T. Hoff and Eli D. Ehrenpreis
Definition
Mesenteric hemorrhage is defined as bleeding occurring from any of the blood
vessels supplying the mesentery, including those also supplying the stomach, small
intestine, pancreas, and spleen.
Epidemiology and Risk Factors
Mesenteric hemorrhage may be related to trauma, infection, malignancy, or vascular malformations, including rupture of splanchnic aneurysms. Mesenteric hemorrhage may be mild and limited to contusions or small hematomas, or severe with
hemodynamic instability and mesenteric devascularization.
Injuries to mesenteric vessels may occur during surgical procedures, including
during direct trocar entry prior to laparoscopy. CT guided biopsy of intra-abdominal
lesions, including pancreatic tumors and cysts, can lead to mesenteric hemorrhage.
Rupture of a mesenteric hematoma may occur following transcatheter aortic valve
replacement (TAVR), which can be life threatening if not identified early. Additional rare causes of mesenteric hemorrhage include labor, electroconvulsive shock
therapy, and endoscopic ultrasound guided fine needle aspiration of pancreatic
lesions. Mesenteric hemorrhage may occur immediately as an intraoperative complication, or in a delayed fashion postoperatively.
19
R. T. Hoff E. D. Ehrenpreis (&)
Department of Medicine, Advocate Lutheran General Hospital, 1775 Dempster St, 6 South,
Park Ridge, IL 60068, USA
e-mail: e2bioconsultants@gmail.com
© Springer Nature Switzerland AG 2021
E. D. Ehrenpreis et al. (eds.), The Mesenteric Organ in Health and Disease,
https://doi.org/10.1007/978-3-030-71963-0_19
171

172 R. T. Hoff and E. D. Ehrenpreis
Rupture of aneurysms and pseudoaneurysms may ca use mesenteric hemorrhage.
Aneurysms of the superior mesenteric artery (SMA) are usually related to infection,
whereas aneurysms of the branching arteries of the SMA are usually due to congenital or acquired medial defects. Compared with other visceral artery aneurysms,
aneurysms of the SMA have a high rate of rupture. Additional causes of splanchnic
aneurysms include infection, atherosclerosis, trauma, pancreatic or biliary tract
disease. Rupture of these aneurysms may occur spontaneously or secondary to
trauma.
In the absence of trauma or recent surgery, mesenteric hemorrhage may occur
spontaneously secondary to an incarcerated inguinal hernia, anticoagulant therapy,
or connective tissue disorders such as Ehlers-Danlos syndrome. Rarely, a mesenteric hematoma may form spontaneously as a complication of a Crohn’s disease
exacerbation. Acute myelogenous leukemia may present with massive mesenteric
hemorrhage. Amyloidosis may involve the mesentery, leading to hemorrhage and
hematoma formation.
Mesenteric hemorrhage may occur spontaneously, leading to abdominal apoplexy (also known as spontaneous hemoperitoneum), though this is very rare.
Historically, abdominal apoplexy has been associated with a high rate of mortality,
reported up to 40 percent. However, modern management and surgery have
improved outcomes (Table 19.1).
Table 19.1 Causes of
Mesenteric Hemorrhage
Systemic
disorders
Local factors Abdominal apoplexy
CT guided biopsy
Electroconvulsive shock therapy
EUS guided biopsy
Surgery
Transcatheter aortic valve replacement
Acute myelogenous leukemia
Amyloidosis
Ehlers-Danlos syndrome
Crohn’s disease exacerbation
Incarcerated inguinal hernia
Labor
Rupture of aneurysm or
pseudoaneurysm
Trauma

19 Mesenteric Hemorrhage 173
Pathophysiology
Mesenteric hemorrhage occurs by several mechanisms, including direct injury to
blood vessels, inflammation leading to aneurysm and subsequent weakening of
vessel walls, and factors that inhibit normal coagulation of blood. Thrombocytopenia and coagulopathy (therapeutic or pathologic) may contribute. Mutations of
the type III procollagen gene may increase the risk in spontaneous mesenteric
hemorrhage.
Symptoms
Ruptured aneurysms present with abdominal pain, nausea, vomiting, and acute
anemia. Rarely, mesenteric hematomas may rupture into the small intestine, leading
to hematochezia. Large mesenteric hematomas may occlude segments of bowel,
leading to bowel obstruction. Patients with underlying coagulopathy or collagen
vascular disease may have bruising, or symptoms of overt bleeding.
Physical Findings
Findings on physical examination may include evidence of acute blood loss,
including hypotension, tachycardia and pallor. Shock may develop if blood loss is
severe. In the setting of trauma, physical exam findings may include
extra-abdominal injuries, such as laceration, ecchymosis, etc. In the event of bowel
injury and peritonitis associated with abdominal trauma, peritoneal findings,
including rebound tenderness and guarding may be present. Laboratory studies may
demonstrate an acute decrease in serum hemoglobin concentration or elevated lactic
acid.
Imaging and Diagnosis
Computed tomography angiography (CTA) of the abdomen provides helpful
information regarding the presence and anatomic extent of mesenteri c hemorrhage
and serves as the imaging test of choice. CTA uses high-resolution datasets with
rapid acquisition times. These are performed at various time intervals after
administration of intravascular contrast material. This results in images obtained as
intravascular contrast is distributed throughout the circulation in the form of multiphasic studies. These in turn can be used to create three dimensional images that
provide great details of the vasculature. CTA is useful for identifying active
bleeding, which is imaged as extravasation of contrast material, while establishing

174 R. T. Hoff and E. D. Ehrenpreis
Fig. 19.1 Coronal image from a CT angiogram shows a left upper quadrant hematoma (asterisks)
with a focus of contrast “blush” (arrow) indicative of active extravasation. There is also diffuse
ascites (A) throughout the abdomen
the source of hemorrhage (See Figs. 19.1 and 19.2). Areas of acute mesenteric
hemorrhage are often heterogeneous and hyperattenuated on CT imaging and repeat
CTA scans can provide information on continued bleeding, thus guiding therapy. If
administered, contrast extravasation into the hematoma indicates ongoing bleeding.
The differential diagnosis of a possible mesenteric hemorrhage includes mesenteric
lymphangioma, abscess, and aneurysm.
Active bleeding into a hematoma may also be established with Technetium 99 m
labeled red blood cell scintigraphy. Acute hemorrhage often exhibits a CT density
of about 35 to 45 hounsfield units. If clots develop, then the density may increase to
70 to 90 hounsfield units. As the hematoma matures, this hyperattenuation gradually decreases, due to breakdown and removal of proteins from red blood cells.
After 2 to 4 weeks following the initial hemorrhage, mesenteric hematomas may be
difficult to distinguish from other similar appearing fluid collections, including
abscesses.
Angiography is an endovascular procedure that provides visualization of the
mesenteric blood vessels and offers an opportunity for therapeutic intervention.
Digital subtraction angiography (DSA) involves the real time digital processing of
contrast enhanced fluoroscopic x-ray images, with removal of unwanted signals and
isolation of desired images. DSA serves as the reference standard for evaluating the
mesenteric vasculature and has demonstrated accuracy in post-pancreatectomy

19 Mesenteric Hemorrhage 175
Fig. 19.2 Axial CT image again demonstrates the diffuse ascites (A) with layering hyperattenuating debris (asterisk) in the left paracolic gutter consistent with blood products. Images are
courtesy of Dr. Abraham Dachman
bleeding. Active bleeding is demonstrated by the extravasation of contrast medium
(Fig. 19.3).
CTA scan is sensitive for identifying mesenteric injuries, including hemorrhage.
CTA is widely used due to its availability, high accuracy, and lack of procedure
related compl ications. Oral contrast can assist in evaluating for concurrent underlying injury to the bowel wall, which is particularly helpful in the setting of trauma.
However, CT imaging with only intravenous (IV) contrast (without oral contrast), is
76% sensitive for all gastrointestinal tract in injuries in trauma patients, and up to
91% sensitive for major injuries, including mesenteric hemorrhage. Oral contrast
may not be necessary in all patients with blunt abdominal trauma but may be useful
in select patients or as follow up to evaluate findings on initial CT imaging.
Blunt abdominal trauma can lead to mesenteric hemorrhage, which can be life
threatening. Active mesenteric hemorrhage can be diagnosed with multiphasic CTA
imaging, which shows extravasation of contrast material into the mesenteric during
the arterial or portal phase. Alternatively, contrast extravasation into the mesentery
that occurs during the equilibrium phase is usually well contained and amenable to
conservative treatment. Bleeding that results in the formation of a hematoma and
tamponade effect may not demonstrate extravasation of contrast and usually does
not require surgical intervention, unless abdominal compartment syndrome or

176 R. T. Hoff and E. D. Ehrenpreis
Fig. 19.3 Digital subtraction angiography following superselective catheterization of a distal
splenic artery branch in the same patient shows irregular contrast blush (arrows) consistent with
active hemorrhage. Images courtesy of Dr. Abraham Dachman and Dr. Justin Ramirez
bowel devascularization develops. Patients with significant extravasation of contrast
material observed on CTA imaging often present with shock or hemodynamic
instability. However, some patients with mesenteric hemorrhage may appear clinically stable despite active bleeding, and CT evidence of ongoing mesenteric
hemorrhage can influence the decision to intervene surgically.
In about one third of cases of spontaneous mesenteric hemorrhage, no active
bleeding or source of bleeding is found. In patients with blunt abdominal trauma
and hemoperitoneum without a clear source of bleeding, mesenteric hemorrhage
should be considered.

19 Mesenteric Hemorrhage 177
Management
For small mesenteric hemorrhages, conservative therapy with monitoring is
appropriate. Often, small bleeds resolve spontaneously, with hemostasis achieved
via intra-abdominal tamponade. Minor bleeding, particularly bleeding from small
vessels and capillaries, may be controlled with vasopressin, which can limit blood
loss via vasoconstriction.
For moderate or severe bleeding involving large vessels, transcatheter
embolization is effective. This approach is particularly suited for hemodynamically
stable patients who have evidence of ongoing bleeding. Transcatheter arterial
embolization is an effective treatment for mesenteric hemorrhage and provides a
less invasive alternative to surgery for achieving hemostasis. If transcatheter
embolization fails to achieve hemostasis, the use of a hydrogel-coated
self-expandable coil may be useful. A transcatheter approach is appropriate in
cases with isolated hemorrhage, in the absence of additional injuries to the
mesentery and bowel. Where clinical suspicion for bowel perforation is high,
surgery is preferable. Since not all centers have the capabi lity of transcatheter
intervention, transfer to a tertiary care center may be necessary. Intestinal infarction
may occur after embolization; however, this complication is rare. Severe bleeding
with hemodynamic instability that does not respond to resuscitation efforts requires
surgery.
Hemorrhage related to abdominal trauma is often associated with additional
injuries, which require surgical intervention. The indicated surgical procedures
depends on operative findings, but may include ligation of injured vessels, resection
of injured bowel, end-to-end anastomosis, etc. Blunt trauma that primarily leads to
active significant blood loss without other maj or visceral injuries, transcather
embolization may be considered. While most cases of vascular injury and mesenteric hemorrhage from laparoscopy require laparotomy with open repair, hemodynamically stable patients may be treated laparoscopically.
Mesenteric hematomas that occur following EUS-FNA should be treated with
broad spectrum antibiotics, as the nutrient rich collection of blood easily becomes
infected by bacteria seeding through the needle tract.
Mesenteric hemorrhage seconda ry to Ehlers Danlos syndrome should be managed with the minimal surgical intervention possible to achieve hemostasis.
Operative management in these patients is complicated by friability of vessels and
surrounding tissue, and poor wound healing (Table 19.2).
Table 19.2 Management of mesenteric hemorrhage
Mild bleeding Supportive care
Serial imaging
Antibiotics (if related to imaging guided biopsy)
Moderate to severe bleeding Transcatheter embolization
Surgical repair, ligation of vessels
Соседние файлы в папке Библиотека им академика М.И. Перельмана
